Insider · CIK 0001178579
Kevin Tang
Files at AUPH (Aurinia Pharmaceuticals Inc.). First filing Dec 9, 2024, latest Aug 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AUPH: Aurinia Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | AUPHbuy Aurinia Pharmaceuticals Inc. | $14M 1,300,000 shares | +13% | +61% from low0% from high | |
| 48Moderate | AUPHbuy Aurinia Pharmaceuticals Inc. | $13M 1,600,000 shares | +19% | - | |
| 43Moderate | AUPHbuy Aurinia Pharmaceuticals Inc. | $11M 1,200,000 shares | +17% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +1,000,000 | $10.12 | $10M | 11,029,500 | Aug 5, 2025 |
| Aug 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +100,000 | $11.34 | $1.1M | 11,129,500 | Aug 5, 2025 |
| Aug 5, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +200,000 | $11.68 | $2.3M | 11,329,500 | Aug 5, 2025 |
| Feb 28, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +399,280 | $7.85 | $3.1M | 8,828,780 | Mar 4, 2025 |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +100,720 | $7.97 | $803k | 8,929,500 | Mar 4, 2025 |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +351,962 | $8.02 | $2.8M | 9,281,462 | Mar 4, 2025 |
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +148,038 | $8.00 | $1.2M | 9,429,500 | Mar 4, 2025 |
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +500,000 | $7.92 | $4.0M | 9,929,500 | Mar 4, 2025 |
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +100,000 | $8.09 | $809k | 10,029,500 | Mar 4, 2025 |
| Dec 5, 2024 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +300,000 | $8.91 | $2.7M | 7,529,500 | Dec 9, 2024 |
| Dec 6, 2024 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +400,000 | $9.01 | $3.6M | 7,929,500 | Dec 9, 2024 |
| Dec 9, 2024 | AUPH Aurinia Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By LP | +500,000 | $9.09 | $4.5M | 8,429,500 | Dec 9, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.